This might be due to the increased level of IL1 cytokines, which leads to chronic inflammation and drives tumor development and progression via the stimulation of the epithelial-to-mesenchymal transition (182), the proliferation of cancer cells, and the enrichment of immunosuppressive cell populations in TME. Here, IL1B is linked to neoplasm.